Cardiac AI Monitoring and Diagnostics Market, By Product (Hardware, Software), By Type (Cardiac Monitoring, Cardiac Diagnostics), By Application (Cardiac Arrhythmias, Ischemia Heart Disease/CAD, Ischemic Stroke and Others), By End-Users (Hospitals, Diagnostic Centers and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Cardiac AI Monitoring and Diagnostics Market was valued at US$ 1.5 Billion in 2024 and is projected to grow at a CAGR of 25.70% to reach US$ 15.3 Billion by 2034. AI (artificial intelligence) allows the accurate prediction of non-invasive diagnosis of coronary artery disease, cardiac outcomes, prediction of outcomes for heart failure patients and detection of malignant arrhythmias and diagnosis in patients.

Growing Prevalence of Cardiovascular Diseases to fuel market growth

Growing prevalence of cardiovascular diseases have become the major factors driving the growth of the Cardiac AI Monitoring and Diagnostics Market. Growing urbanization has given rise to increased consumption of processed foods, frozen packed foods, animal-derived foods, and a lack of physical activity, which affect the health of human beings and cause chronic diseases like heart disease, diabetes, obesity, high blood pressure, and gastrointestinal diseases which in turn drives the Cardiac AI Monitoring and Diagnostics Market growth.

Further,  according to the CDC (Centers for Disease Control and Prevention), in the United States, around 697,000 people died from heart disease, and around 20.1 million adults aged 20 and older are suffering from coronary artery disease (CAD), which in turn supports the growth of Cardiac AI Monitoring and Diagnostics Market.

Technological Advancement to fuel market growth

Technological advancement in cardiac diagnostics have become another major factor in target market growth. Advancement in AI monitoring and diagnostics of cardiac has provided early detection of heart conditions, AI-powered algorithms analyze huge amount of cardiac data with improved accuracy and efficiency. AI monitoring also help in tracking patient’s heart health outside healthcare setting which leads to reduced hospitalization, better disease management with improved patient convenience which is likely to propel Cardiac AI Monitoring and Diagnostics Market growth.

Restrains:

However, expensive implementation of AI and low adoption of AI-based solutions in cardiac diagnosis has hampered the demand for Cardiac AI Monitoring and Diagnostics Market growth.

Cardiac AI Monitoring and Diagnostics Market is segmented based on Product, Type, Application, End-Users and Region.

Product Insight

On the basis of Product, Cardiac AI Monitoring and Diagnostics Market is segmented Hardware, Software.

Type Insight

On the basis of Type, Cardiac AI Monitoring and Diagnostics Market is segmented Cardiac Monitoring, Cardiac Diagnostics (ECG-based, Imaging and Others)

Application Insight

On the basis of Application, Cardiac AI Monitoring and Diagnostics Market is segmented Cardiac Arrhythmias, Ischemia Heart Disease/CAD, Ischemic Stroke and Others.

End-Users Insights

On the basis of End-Users, Cardiac AI Monitoring and Diagnostics Market is segmented into Hospitals, Diagnostic Centers and Others.

Cardiac AI Monitoring and Diagnostics Market Regional Insights:

On region the Cardiac AI Monitoring and Diagnostics Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

North America market is estimated to witness a significantly high revenue share over the forecast period due to growing prevalence of cardiovascular disease, huge research and development activities, technological advancement, government initiatives, and increasing healthcare expenditure.

For instance, according to CDC (Centers for Disease Control and Prevention) around US $229 billion was spend for cardiovascular diseases in United States.

Asia Pacific market is estimated to witness a fastest revenue share over the forecast period due to growing geriatric population, improved healthcare infrastructure, and growing economic status.

Recent Development:

The New Launched Product News,

• In June 2023, BIOTRONIK launched new AI-powered cardiac monitor implants. The new launched ‘BIOMONITOR IV’ implantable cardiac monitor pairs with SmartECG technology with AI (artificial intelligence) that help in reducing false positive detections by 86% and preserves 98% of true episodes.
• In March 2023, Aidoc launched new cardiovascular AI (artificial intelligence) solutions at opening of the American College of Cardiology (ACC) 2023 annual meeting in New Orleans. The new launched cardiac AI-based solution automatically help in consolidating data by utilizing AI for generating clinical insights for more effective and improved diagnosis.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034.

Few Other Promising Reports:

• AI-Enabled Drug Discovery and Clinical Trials Market
• Implantable Cardioverter Defribillator Market

The key players operating the Cardiac AI Monitoring and Diagnostics Market includes, GE Healthcare, Koinklijke Philips N.V., Siemens Healthineers, CardiAI, IDOVEN, DiA Imaging Analysis, Cleerly Inc., Ultronmics Limited, RSIP Vision, Aidoc, and Others.